FinanceCity
HealthcareNSE · BSE

Bliss GVS Pharma Limited

BLISSGVS · ISIN INE416D01022

Share price

₹436 -0.90%

Market capitalisation

₹4620 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹4620 Cr

Current price

₹436

-0.90% today

52W high

₹463

52W low

₹118

Stock P/E

36.3

P/B ratio

4.06

02 · Per share & returns

EPS (TTM)

₹12.00

Book value

₹107

ROE

ROA

Dividend yield

0.23%

Beta

1.17

03 · Financials (TTM)

By the numbers

Revenue

₹868 Cr

+29.80% YoY

EBITDA

₹134 Cr

Net profit

₹109 Cr

+124.70% YoY

Profit margin

12.57%

Operating margin

13.92%

Total debt

₹21.75 Cr

Total cash

₹168 Cr

Debt / equity

0.02x

Current ratio

Payout ratio

8.33%

04 · Analyst view

Target price

Upside

Consensus

NONE

Analysts

05 · Shareholding pattern

Who owns BLISSGVS?

Shareholding pattern not yet captured for this company. Pulled from NSE corporate filings on the next ownership refresh.

06 · Registration & listing

On the record

Symbol
BLISSGVS
Exchange
NSE · BSE
CIN
ISIN
INE416D01022
BSE code
506197
Sector
Healthcare
Industry
Face value
₹1
Listing date
25 Jul 2010
Employees
966
Headquarters
Mumbai, India

07 · About

What is Bliss GVS Pharma Limited?

Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotion, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, shampoo, soaps, sprays, and vaginal washes. In addition, it offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

08 · Common questions

Frequently asked

What is the CIN of Bliss GVS Pharma Limited?+

The Corporate Identity Number for Bliss GVS Pharma Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Bliss GVS Pharma Limited?+

Promoter and group-holding details for Bliss GVS Pharma Limited are disclosed quarterly via stock-exchange filings. Detailed pattern is refreshed weekly here from BSE and NSE corporate filings.

What is the market capitalisation of Bliss GVS Pharma Limited?+

Bliss GVS Pharma Limited (BLISSGVS) has a market capitalisation of approximately ₹4620 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →